INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer

Area of Science:

• Epigenetics
• Cancer Biology
• Molecular Oncology

Background:

• ATP-dependent chromatin remodeling complexes regulate gene expression and are frequently altered in cancer.
• The role of the INO80 complex in cancer initiation and progression remains largely unclear.
• Understanding chromatin remodeler functions is crucial for developing novel cancer therapies.

Purpose of the Study:

• To investigate the role of the INO80 chromatin remodeling complex in non-small-cell lung cancer (NSCLC).
• To determine the correlation between INO80 expression and patient prognosis.
• To explore INO80's function in regulating oncogenic transcription and tumor growth.

Main Methods:

• Analysis of INO80 and Ino80B subunit expression in NSCLC patient data.
• Functional assays including cell proliferation, anchorage-independent growth, and tumor formation in mouse xenografts upon INO80 silencing.
• Chromatin immunoprecipitation sequencing (ChIP-seq) to identify INO80 binding sites and assess genome accessibility.

Main Results:

• INO80 is highly expressed in NSCLC cells and its expression correlates with poor patient prognosis.
• Silencing INO80 significantly inhibits NSCLC cell proliferation and tumor growth in vivo.
• INO80 occupies enhancer regions of lung cancer-associated genes, promoting their expression and increasing genome accessibility.

Conclusions:

• The INO80 complex is essential for oncogenic transcription and tumorigenesis in NSCLC.
• INO80 represents a promising therapeutic target for inhibiting cancer transcription networks in lung cancer.
• Targeting INO80 may offer a novel treatment strategy for NSCLC.